SCHEMBL285426

SCHEMBL285426

C[C@H](C(=O)O)[C@@](C)(O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.33
PTGS1 P23219 1/20 0.33
HMGCR P04035 1/20 0.32
CHRM1 P11229 1/20 0.32
TBXA2R P21731 1/20 0.32
ADRA1A P35348 1/20 0.32
SLC7A5 Q01650 1/20 0.32
CYP2D6 P10635 2/20 0.31
HIF1A Q16665 2/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TET2 Q6N021 1/20 0.30
CPT2 P23786 1/20 0.30
ACLY P53396 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15908131 1.00 TSHR (0.45) TSHRALDH1A1TP53MAPTPTGS1
SCHEMBL104478 1.00 TSHR (0.45) TSHRALDH1A1TP53MAPTPTGS1
SCHEMBL18832123 1.00 TSHR (0.45) TSHRALDH1A1TP53MAPTPTGS1
SCHEMBL1924478 1.00 TSHR (0.45) TSHRALDH1A1TP53MAPTPTGS1
SCHEMBL1085851 0.79
SCHEMBL503261 0.79
SCHEMBL1576713 0.79
SCHEMBL1300583 0.79 ALDH1A1 (0.41) TSHRALDH1A1TET2
SCHEMBL11396749 0.79 ALDH1A1 (0.41) TSHRALDH1A1MAPTPTGS1CYP2D6
SCHEMBL3138263 0.77 ALDH1A1 (0.33) TSHRALDH1A1TP53MAPTPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106119113-B Organisms for the production of 1, 3-butanediol 基因组股份公司 2026-05-12 CN disclosed
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US disclosed
US-12529078-B2 Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis GENOMATICA, INC. (US) 2026-01-20 US disclosed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 US disclosed
US-20240294950-A1 MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS AGAIN BIO APS (DK) 2024-09-05 US disclosed
EP-4421181-A2 NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY Genomatica, Inc. (US) 2024-08-28 EP disclosed
EP-4389904-A2 MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO Genomatica, Inc. (US) 2024-06-26 EP disclosed
US-20240182935-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2024-06-06 US disclosed
EP-3741865-B1 NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY GENOMATICA INC (US) 2024-03-13 EP disclosed
EP-3164495-B1 MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO GENOMATICA INC (US) 2024-02-28 EP disclosed
EP-2440669-A2 MICROORGANISMS AND METHODS FOR CARBON-EFFICIENT BIOSYNTHESIS OF MEK AND 2-BUTANOL Genomatica, Inc. (US) 2012-04-18 EP disclosed
EP-2427544-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID Genomatica, Inc. (US) 2012-03-14 EP disclosed
WO-2012018624-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE GENOMATICA, INC. (US) 2012-02-09 WO disclosed
US-20120021478-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE AGAIN BIO APS (DK) 2012-01-26 US disclosed
US-20110201068-A1 MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ISOPROPANOL WITH PRIMARY ALCOHOLS, DIOLS AND ACIDS GENOMATICA, INC. 2011-08-18 US disclosed
US-20110008858-A1 MICROORGANISMS AND METHODS FOR CARBON-EFFICIENT BIOSYNTHESIS OF MEK AND 2-BUTANOL GENOMATICA, INC. 2011-01-13 US disclosed
US-20100330635-A1 ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL GENOMATICA, INC. (US) 2010-12-30 US disclosed
US-20100317069-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2010-12-16 US disclosed
WO-2010144746-A2 MICROORGANISMS AND METHODS FOR CARBON-EFFICIENT BIOSYNTHESIS OF MEK AND 2-BUTANOL GENOMATICA, INC. (US) 2010-12-16 WO disclosed
WO-2010129936-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529078-B2 Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis ALDOA, FDPS, DERA TSHR 4558/4885ALDH1A1 385/4885TP53 3429/4885
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 TSHR 3382/4885ALDH1A1 1822/4885TP53 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.